Gilead's hep B drug as effective as Viread but safer

January 5, 2016 2:22 PM

30 0

Gilead Sciences Inc said its experimental hepatitis B drug was found safer than but as effective as its approved treatment, Viread, in two late-stage studies.

The once-daily drug, tenofovir alafenamide (TAF), showed improved renal and bone safety compared with Viread, Gilead said on Tuesday.

Read more

To category page